Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02457546 · ClinicalTrials.gov registry record · Phase 3
The EVICEL® Neurosurgery Phase III Study
A Phase 3 study, sponsored by Ethicon.
- Completed
- Registry status
- Phase 3
- Development phase
- 234
- Enrollment target
NCT02457546 is a Phase 3 study that has completed, run by Ethicon. The registered enrollment target is 234 participants.
The verdict
NCT02457546, a Phase 3 study, has completed, sponsored by Ethicon.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 234 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate the safety and efficacy of EVICEL® Fibrin Sealant (Human) for use as an adjunct to sutured dural repair in cranial surgery.
Interventions
- BIOLOGICAL EVICEL Fibrin Sealant
- DEVICE Hydrogel sealant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 234 participants |
| Start Date | 2015-07-01 |
| Est. Completion | 2017-10-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02457546
The ClinicalTrials.gov registry entry for NCT02457546 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 234 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ethicon, which has 38 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which EVICEL Fibrin Sealant is the first listed.
NCT02457546 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02457546 about?
NCT02457546 is a clinical study titled "The EVICEL® Neurosurgery Phase III Study". The objective of this study is to evaluate the safety and efficacy of EVICEL® Fibrin Sealant (Human) for use as an adjunct to sutured dural repair in cranial surgery.
What is the current status of trial NCT02457546?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 234 participants. The study started on 2015-07-01. Estimated completion is 2017-10-12.
What interventions are being tested in trial NCT02457546?
The interventions under investigation include: EVICEL Fibrin Sealant (BIOLOGICAL), Hydrogel sealant (DEVICE).
Who is sponsoring clinical trial NCT02457546?
This trial is sponsored by Ethicon, which has 38 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.